Cargando…
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
Early detection, right therapeutic intervention, and simultaneous effectiveness mapping are considered the critical factors in successful cancer therapy. Nevertheless, these factors experience the limitations of conventional cancer diagnostics and therapeutics delivery approaches. Along with providi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823416/ https://www.ncbi.nlm.nih.gov/pubmed/33374391 http://dx.doi.org/10.3390/pharmaceutics13010024 |
_version_ | 1783639830718054400 |
---|---|
author | Alshehri, Sultan Imam, Syed Sarim Rizwanullah, Md. Akhter, Sohail Mahdi, Wael Kazi, Mohsin Ahmad, Javed |
author_facet | Alshehri, Sultan Imam, Syed Sarim Rizwanullah, Md. Akhter, Sohail Mahdi, Wael Kazi, Mohsin Ahmad, Javed |
author_sort | Alshehri, Sultan |
collection | PubMed |
description | Early detection, right therapeutic intervention, and simultaneous effectiveness mapping are considered the critical factors in successful cancer therapy. Nevertheless, these factors experience the limitations of conventional cancer diagnostics and therapeutics delivery approaches. Along with providing the targeted therapeutics delivery, advances in nanomedicines have allowed the combination of therapy and diagnostics in a single system (called cancer theranostics). This paper discusses the progress in the pre-clinical and clinical development of therapeutics, diagnostics, and theranostics cancer nanomedicines. It has been well evident that compared to the overabundance of works that claimed success in pre-clinical studies, merely 15 and around 75 cancer nanomedicines are approved, and currently under clinical trials, respectively. Thus, we also brief the critical bottlenecks in the successful clinical translation of cancer nanomedicines. |
format | Online Article Text |
id | pubmed-7823416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78234162021-01-24 Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges Alshehri, Sultan Imam, Syed Sarim Rizwanullah, Md. Akhter, Sohail Mahdi, Wael Kazi, Mohsin Ahmad, Javed Pharmaceutics Review Early detection, right therapeutic intervention, and simultaneous effectiveness mapping are considered the critical factors in successful cancer therapy. Nevertheless, these factors experience the limitations of conventional cancer diagnostics and therapeutics delivery approaches. Along with providing the targeted therapeutics delivery, advances in nanomedicines have allowed the combination of therapy and diagnostics in a single system (called cancer theranostics). This paper discusses the progress in the pre-clinical and clinical development of therapeutics, diagnostics, and theranostics cancer nanomedicines. It has been well evident that compared to the overabundance of works that claimed success in pre-clinical studies, merely 15 and around 75 cancer nanomedicines are approved, and currently under clinical trials, respectively. Thus, we also brief the critical bottlenecks in the successful clinical translation of cancer nanomedicines. MDPI 2020-12-24 /pmc/articles/PMC7823416/ /pubmed/33374391 http://dx.doi.org/10.3390/pharmaceutics13010024 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Alshehri, Sultan Imam, Syed Sarim Rizwanullah, Md. Akhter, Sohail Mahdi, Wael Kazi, Mohsin Ahmad, Javed Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges |
title | Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges |
title_full | Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges |
title_fullStr | Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges |
title_full_unstemmed | Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges |
title_short | Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges |
title_sort | progress of cancer nanotechnology as diagnostics, therapeutics, and theranostics nanomedicine: preclinical promise and translational challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823416/ https://www.ncbi.nlm.nih.gov/pubmed/33374391 http://dx.doi.org/10.3390/pharmaceutics13010024 |
work_keys_str_mv | AT alshehrisultan progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges AT imamsyedsarim progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges AT rizwanullahmd progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges AT akhtersohail progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges AT mahdiwael progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges AT kazimohsin progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges AT ahmadjaved progressofcancernanotechnologyasdiagnosticstherapeuticsandtheranosticsnanomedicinepreclinicalpromiseandtranslationalchallenges |